Teachers at high schools in the Netherlands have gained a new task: monitoring restrooms. They enter during breaks and between classes and consistently find groups of students in toilet stalls enveloped in a sweet cloud of peach, strawberry or banana toffee pie scent. Within 7 s, the high-dose nicotine rushes from their lungs to their brains, fulfilling the enormous craving they were experiencing for the last hour. In every school in the Netherlands – perhaps every school in Europe – there are students addicted to e-cigarettes. It’s forbidden, but forbidden fruits have always tasted the best to teenagers, and with high doses of nicotine involved, the temptation is impossible to resist. If you think back to your 13-year-old self, could you have resisted lemon meringue pie flavor packaged in a brightly colored, high-tech device?
Global e-cigarette use among teenagers continues to rise [1,2,3]. In the Netherlands, some 25% of youths have experimented with vaping [4]. In this issue of the European Journal of Pediatrics, To et al. illustrate that e-cigarettes have direct adverse effects on Canadian adolescents, negatively affecting stress levels and quality of life [5]. These results echo similar findings in the United States and Europe [6,7,8] and reflect what has been shown in animal models [9, 10]: nicotine is a detrimental factor in a developing adolescent brain [11]. Nicotine use in childhood results in an increased likelihood of developing psychiatric and cognitive disorders later in life [6, 10]. However, the most concerning statistic is the robust evidence indicating that e-cigarettes serve as a gateway to traditional cigarette use. Once exposed to nicotine, two-thirds of adolescent e-cigarette users will transfer to smoking tobacco [12,13,14,15].
Next to nicotine, e-cigarette aerosols contain an array of chemicals and metals, leading to cellular and DNA damage [16], increased risk of chronic bronchitis and asthma exacerbations [17, 18], compromised immunity [19], and potentially life-threatening conditions such as EVALI (e-cigarette or vaping product use-associated lung injury) [20]. Long-term effects are being awaited, but there are grounded concerns for e-cigarette-related cancer and vascular and pulmonary diseases.
Candy-colored, sweet-smelling nicotine carriers: the Trojan Horse of the 2020’s
Initially, the e-cigarette was introduced in the early 2000s as a smoking cessation aid. In fact, a recent landmark clinical trial [21], along with an editorial [22], directs to healthcare professionals that “it is now time … to … add e-cigarettes to the smoking-cessation toolkit’’ and to “reconsider their cautious positions on e-cigarettes for smoking cessation.” This statement was based on an added 12.6% increase in successful tobacco smoking cessation using e-cigarettes compared to a control group with traditional smoking cessation measures. Interestingly, the control group had a significantly higher amount of participants stopping nicotine altogether. Thus, comparing the two-thirds of adolescent e-cigarette users transforming into tobacco smokers to the extra 12.6% of tobacco smokers who quit smoking cigarettes with the help of e-cigarettes, the total number of tobacco users in society may well rise.
The authors and the editors of the New England Journal of Medicine, where the study was published, seem to underestimate the fact that e-cigarette endorsements strongly contribute to the unwarranted positive perception of e-cigarettes within society. This ‘healthier’ image of the e-cigarette has significantly contributed to its approval in many countries all over the world and rapid rise in sales. Combined with big tobacco’s aggressive marketing with flashy designs, vibrant colors, and enticing flavors, this led to an increase in e-cigarette use, specifically among teenagers – by some called ‘the vaping epidemic’ [23].
What can healthcare providers do?
It’s well recognized globally that government-led initiatives to discourage behavior are most effective: raising prices via taxation, reducing points of sale, banning e-cigarettes and implementing legislation to secure a tobacco- and nicotine end-game. However, a typical pattern seen is that every change in government is seized as an opportunity to renegotiate. Contrary to article 5.3 of the WHO FCTC [24], which calls on parties to protect public health policies from the commercial interests of the tobacco industry, the tobacco industry often manages to influence decisions [25].
Medical doctor Judith Mackay, an international anti-tobacco control advocate and senior adviser to the WHO, describes the ‘tobacco scream test’ to gauge the effectiveness of anti-tobacco measures. If the tobacco industry screams, a measure is undoubtedly effective. If not, then the measure probably will have no significant effect [26]. The tobacco industry screams at taxes and bans, but it screams much less at health education.
Health education targeting adolescents, whom peers and social media mainly influence, is tricky. The most evidence-based prevention model seems to be the social competence or influence model [27, 28]. These are based on social impact and intervene in a multi-setting, such as school, (sports) clubs, parenting, (social) media and medical professionals. The interventions should be repeated periodically, as their effect wears off quickly when they stop [29].
Meanwhile however, the vaping epidemic is raging, and young people are becoming addicted in droves. For healthcare providers, the question arises of whether it is still justifiable to stand idly by. Even though health education may not be the most effective measure, failing to inform young people about how addictive e-cigarettes are and not providing any counter-narrative against the widespread misinformation about vaping on social media cannot be easily morally justified.
What are we doing in the Netherlands?
Countrywide, Dutch physicians could no longer tolerate witnessing ‘the smoke-free’ generation go up in smoke. Multiple initiatives are active; '#artsenslaanalarm, a coalition of physicians united to achieve a smoke-free society, is raising awareness through impactful campaigns funded by the National Knowledge Institute for mental health, alcohol, tobacco, and drug use [30, 31].
As medical doctors specializing in pediatric lung disase and lung cancer, we are confronted daily with the devastating consequences of smoking from an early age. Aware of the research delineating effective and ineffective prevention strategies, we sought to counteract the pervasive dissemination of misinformation. Given the tobacco industry’s deliberate targeting of young individuals, we deemed it essential to intervene at this critical juncture. Disposable e-cigarettes typically attract users as young as 14 to 15 years old; hence, we specifically targeted 12–14-year-olds. To achieve this, we developed a concise educational package accessible to teachers via a Dutch website (www.vapenjouwkeuze.nl) [32]. Additionally, we offered medical doctor guest lectures in classrooms upon request. Since the initiation in October 2023, over 5500 educational packages have been downloaded nationwide, with over 1000 schools requesting doctor’s guest lectures. Across various cities and medical specialties, over 700 physicians driven by a shared aversion against the e-cigarette epidemic and provided with standard learning materials have volunteered to deliver these educational sessions (See Fig. 1). This joint, continuously expanding effort has now garnered significant attention from national media and political platforms.
Let’s dive in together
The study by To et al. in this issue of the European Journal [5] underscores the need for our actions. We have promised in our Hippocratic oath to drive the prevention of disease. In this case, we have to team up with all healthcare advocates to keep stressing the responsibility of the government to safeguard its youth and protect them against the tobacco industry. In the meantime, we will continue our prevention journey, providing schools and colleagues with (translatable) material to educate our youth. Let’s clean the high school toilets from e-cigarettes and make sure these can serve their original purpose: providing a safe house for gossip and cheat sheets.
References
Buss V, Kock L, Beard E, Kale D, Brown J (2023) Trends in electronic cigarette use in England. (E-cigarettes) the information gained on 20th March 2024
Jiahong S, Xi B, Ma C, Zhao M, Bovet P (2022) Prevalence of e-cigarette use and its associated factors among youths aged 12 to 16 years in 68 countries and territories: global youth tobacco survey, 2012–2019. Am J Public Health 112:650661. https://doi.org/10.2105/AJPH.2021.306686
Kim J, Lee S, Chun J (2022) An international systematic review of prevalence, risk, and protective factors associated with young people’s e-cigarette use. Int J Environ Res Public Health 19:11570. https://doi.org/10.3390/ijerph191811570
Schaap J, Troelstra S, Croes E, Willemsen M, et al, https://www.trimbos.nl/wp-content/uploads/2023/10/AF2113-Elektronische-sigaretten-vapes.pdf
To T, Borkhoff CM, Chung-Wai C, Moraes TJ, Schwartz R, Vozoris N, Lal A, Yen W, Zhang K, Terebessy E, Zhu J (2024) Association of ever use of e-cigarettes with health and lifestyle variables among young adults: a Canadian health measure survey study. Eur J Pediatr
Gorfinkel L, Hasin D, Miech R, Keyes KM (2022) The link between depressive symptoms and vaping nicotine in U.S. adolescents, 2017–2019. J Adolesc Health 70(1):133–139
Becker TD, Arnold MK, Ro V, Martin L, Rice TR (2021) Systematic review of electronic cigarette use (vaping) and mental health comorbidity among adolescents and young adults. Nicotine Tob Res 23(3):415–425
Bandiera FC, Loukas A, Wilkinson AV, Perry CL (2016) Associations between tobacco and nicotine product use and depressive symptoms among college students in Texas. Addict Behav 63:19–22
Ponzoni L, Moretti M et al (2015) Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Eur Neuropsychopharmacol 25(10):1775–1786
Zelikoff JR, Parmalee NL et al (2018) Microglia activation and gene expression alteration of neurotrophins in the hippocampus following early-life exposure to e-cigarette aerosols in a murine model. Toxicol Sci 162(1):276–286. https://doi.org/10.1093/toxsci/kfx257
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (2016) Health effects of e-cigarette use. E-cigarette use among youth and young adults: a report of the surgeon general. Centers for Disease Control and Prevention (US)
Khouja JN, Suddell SF, Peters SE, Taylor AE, Munafò MR (2021) Is e-cigarette use in non-smoking young adults associated with later smoking? A systematic review and meta-analysis. Tob Control 30(1):8–15
Chan GCK, Stjepanović D, Lim C et al (2021) Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation. Addiction 116(4):743–756
Berry KM, Fetterman JL, Benjamin EJ et al (2019) Association of electronic cigarette use with subsequent initiation of tobacco cigarettes in US youths. JAMA Netw Open 2(2):e187794
Soneji S, Barrington-Trimis JL, Wills TA et al (2017) Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults a systematic review and meta-analysis. JAMA Pediatr 171(8):788–797
Corbett S, Nitzberg M et al (2019) Gene expression alterations in the bronchial epithelium of e-cigarette users. Chest 156(4):764–773
McConnell R, Barrington-Trimis JL et al (2017) Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med 195(8):1043–1049. https://doi.org/10.1164/rccm.201604-0804OC
Alnajem A, Redha A et al (2020) Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study. Respir Res 21(1):300. https://doi.org/10.1186/s12931-020-01569-9
Davis LC, Sapey E, Thickett DR, Scott A (2022) Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing? Eur Respir Rev 31(163):35022257. https://doi.org/10.1183/16000617.0121-2021
Layden JE, Ghinai I, Pray I et al (2019) Pulmonary illness related to e-cigarette use in Illinois and Wisconsin—preliminary report. N Engl J Med. NEJMoa1911614 https://doi.org/10.1056/NEJMoa1911614. Epub 2019 Sep 6. PMID: 31491072.
Auer R, Schoeni A et al (2024) Electronic nicotine-delivery systems for smoking cessation. N Engl J Med 390:601–610. https://doi.org/10.1056/NEJMoa2308815
Rigotti NA (2024) Electronic cigarettes for smoking cessation — have we reached a tipping point? N Engl J Med 390:664–665. https://doi.org/10.1056/NEJMe2314977
UK health expert (2023) Raises alarm at vaping ‘epidemic’ among teenagers. The Guardian
WHO Framework Convention on Tobacco Control Overview. https://fctc.who.int/who-fctc/overview. Accessed 25 Mar 2024
Mapping the tobacco lobby in Brussels: Smoky business. Corporate Europe Observatory. https://corporateeurope.org/en/lobbycracy/2012/11/mapping-tobacco-lobby-brussels-smoky-business. Accessed 25 Mar 2024
Tobacconomics. How big tobacco uses dodgy data to ‘throw sand in the gears’ of Global Health Policy. ISBN: 978-1-872428-86-4
Flay BR (2009) School-based smoking prevention programs with the promise of long-term effects. Tob Induc Dis 5(March):6. https://doi.org/10.1186/1617-9625-5-6
Liu J, Mathur G, Aiha S, Halpern-Felsher B (2020) A breath of knowledge: overview of current adolescent e-cigarette prevention and cessation programs. Curr Addict Rep Volume 7:520–532
Krowchuk HV (2005) Effectiveness of adolescent smoking prevention strategies. MCN Am J Matern Child Nurs 30(6):366–372. https://doi.org/10.1097/00005721-200511000-00004. Accession Number: 16260941
Artsen slaan alarm. https://artsenslaanalarm.nl/. Accessed 25 Mar 2024
Trimbos-instituut. Helder op school. https://www.trimbos.nl/aanbod/programmas/helder-op-school/. Accessed 25 Mar 2024
Vapen Jouw Keuze. www.vapenjouwkeuze.nl. Accessed 25 Mar 2024
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Borm, F.J., Cohen, S., Milani, G.P. et al. I will prevent disease whenever I can, for prevention is preferable to cure: doctors’ role in the vaping epidemic. Eur J Pediatr (2024). https://doi.org/10.1007/s00431-024-05548-w
Published:
DOI: https://doi.org/10.1007/s00431-024-05548-w